SEC Filing Details

Detailed Financial Reporting & Filings

Access Aprea Therapeutics’ quarterly and annual reports, earnings disclosures, and SEC filings. These financial documents reflect our commitment to transparency, regulatory compliance, and delivering clear insight into our operational and fiscal performance.

Document Details

Form
Filing Date
Mar 30, 2026
Document Date
Mar 30, 2026
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Aprea Therapeutics
Issuer
Aprea Therapeutics, Inc.